MS Kegg pathways

hsa04060 Cytokine-cytokine receptor interaction - Homo sapiens (human) (52)

hsa:6346 CCL1; chemokine (C-C motif) ligand 1 hsa:6356 CCL11; chemokine (C-C motif) ligand 11 hsa:6357 CCL13; chemokine (C-C motif) ligand 13 hsa:6358 CCL14; chemokine (C-C motif) ligand 14 hsa:6359 CCL15; chemokine (C-C motif) ligand 15 hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:6348 CCL3; chemokine (C-C motif) ligand 3 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:6354 CCL7; chemokine (C-C motif) ligand 7 hsa:729230 CCR2; chemokine (C-C motif) receptor 2 hsa:1234 CCR5; chemokine (C-C motif) receptor 5 (gene/pseudogene) hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:1270 CNTF; ciliary neurotrophic factor hsa:3627 CXCL10; chemokine (C-X-C motif) ligand 10 hsa:6387 CXCL12; chemokine (C-X-C motif) ligand 12 hsa:7852 CXCR4; chemokine (C-X-C motif) receptor 4 hsa:643 CXCR5; chemokine (C-X-C motif) receptor 5 hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3558 IL2; interleukin 2 hsa:59067 IL21; interleukin 21 hsa:50615 IL21R; interleukin 21 receptor hsa:116379 IL22RA2; interleukin 22 receptor, alpha 2 hsa:149233 IL23R; interleukin 23 receptor hsa:3559 IL2RA; interleukin 2 receptor, alpha hsa:3560 IL2RB; interleukin 2 receptor, beta hsa:3565 IL4; interleukin 4 hsa:3566 IL4R; interleukin 4 receptor hsa:3568 IL5RA; interleukin 5 receptor, alpha hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3574 IL7; interleukin 7 hsa:3575 IL7R; interleukin 7 receptor hsa:3576 IL8; interleukin 8 hsa:4049 LTA; lymphotoxin alpha (TNF superfamily, member 1) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a hsa:8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10 hsa:8740 TNFSF14; tumor necrosis factor (ligand) superfamily, member 14

hsa05164 Influenza A - Homo sapiens (human) (38)

hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:4261 CIITA; class II, major histocompatibility complex, transactivator hsa:3627 CXCL10; chemokine (C-X-C motif) ligand 10 hsa:5610 EIF2AK2; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:64135 IFIH1; interferon induced with helicase C domain 1 (EC:3.6.4.13) hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4599 MX1; myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4938 OAS1; 2'-5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:7124 TNF; tumor necrosis factor hsa:8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a hsa:8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10 hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa05168 Herpes simplex infection - Homo sapiens (human) (34)

hsa:727 C5; complement component 5 hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:5610 EIF2AK2; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:64135 IFIH1; interferon induced with helicase C domain 1 (EC:3.6.4.13) hsa:3434 IFIT1; interferon-induced protein with tetratricopeptide repeats 1 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:4049 LTA; lymphotoxin alpha (TNF superfamily, member 1) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4938 OAS1; 2'-5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6891 TAP2; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:8740 TNFSF14; tumor necrosis factor (ligand) superfamily, member 14 hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa05152 Tuberculosis - Homo sapiens (human) (33)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:929 CD14; CD14 molecule hsa:4261 CIITA; class II, major histocompatibility complex, transactivator hsa:1520 CTSS; cathepsin S (EC:3.4.22.27) hsa:1594 CYP27B1; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:10892 MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:64127 NOD2; nucleotide-binding oligomerization domain containing 2 hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:7421 VDR; vitamin D (1,25- dihydroxyvitamin D3) receptor

hsa05162 Measles - Homo sapiens (human) (32)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:940 CD28; CD28 molecule hsa:4179 CD46; CD46 molecule, complement regulatory protein hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:5610 EIF2AK2; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:64135 IFIH1; interferon induced with helicase C domain 1 (EC:3.6.4.13) hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3558 IL2; interleukin 2 hsa:3559 IL2RA; interleukin 2 receptor, alpha hsa:3560 IL2RB; interleukin 2 receptor, beta hsa:3565 IL4; interleukin 4 hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:4599 MX1; myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4938 OAS1; 2'-5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a hsa:8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b hsa:8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10 hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa04650 Natural killer cell mediated cytotoxicity - Homo sapiens (human) (30)

hsa:962 CD48; CD48 molecule hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3802 KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 hsa:3803 KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 hsa:3804 KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 hsa:3806 KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 hsa:3811 KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4277 MICB; MHC class I polypeptide-related sequence B hsa:5551 PRF1; perforin 1 (pore forming protein) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7124 TNF; tumor necrosis factor hsa:8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a hsa:8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b hsa:8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10 hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa01100 Metabolic pathways - Homo sapiens (human) (29) (No Map available)

hsa:4508 ATP6; ATP synthase F0 subunit 6 hsa:10317 B3GALT5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 hsa:56913 C1GALT1; core 1 synthase, glycoprotein-N-acetylgalactosamine 3-beta-galactosyltransferase, 1 (EC:2.4.1.122) hsa:1589 CYP21A2; cytochrome P450, family 21, subfamily A, polypeptide 2 (EC:1.14.99.10) hsa:1591 CYP24A1; cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) hsa:1594 CYP27B1; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) hsa:4519 CYTB; cytochrome b hsa:1717 DHCR7; 7-dehydrocholesterol reductase (EC:1.3.1.21) hsa:2135 EXTL2; exostoses (multiple)-like 2 (EC:2.4.1.223) hsa:2530 FUT8; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68) hsa:9563 H6PD; hexose-6-phosphate dehydrogenase (glucose 1-dehydrogenase) (EC:1.1.1.47 3.1.1.31) hsa:3632 INPP5A; inositol polyphosphate-5-phosphatase, 40kDa (EC:3.1.3.56) hsa:4524 MTHFR; methylenetetrahydrofolate reductase (NAD(P)H) (EC:1.5.1.20) hsa:4535 ND1; NADH dehydrogenase, subunit 1 (complex I) hsa:4536 ND2; MTND2 hsa:4537 ND3; NADH dehydrogenase, subunit 3 (complex I) hsa:4538 ND4; NADH dehydrogenase, subunit 4 (complex I) hsa:4540 ND5; NADH dehydrogenase, subunit 5 (complex I) hsa:4725 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) hsa:374291 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:7941 PLA2G7; phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) (EC:3.1.1.47) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5409 PNMT; phenylethanolamine N-methyltransferase (EC:2.1.1.28) hsa:5444 PON1; paraoxonase 1 (EC:3.1.1.2 3.1.8.1 3.1.1.81) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) hsa:55312 RFK; riboflavin kinase (EC:2.7.1.26) hsa:6489 ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (EC:2.4.99.8)

hsa04630 Jak-STAT signaling pathway - Homo sapiens (human) (29)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:1270 CNTF; ciliary neurotrophic factor hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3558 IL2; interleukin 2 hsa:59067 IL21; interleukin 21 hsa:50615 IL21R; interleukin 21 receptor hsa:116379 IL22RA2; interleukin 22 receptor, alpha 2 hsa:149233 IL23R; interleukin 23 receptor hsa:3559 IL2RA; interleukin 2 receptor, alpha hsa:3560 IL2RB; interleukin 2 receptor, beta hsa:3565 IL4; interleukin 4 hsa:3566 IL4R; interleukin 4 receptor hsa:3568 IL5RA; interleukin 5 receptor, alpha hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3574 IL7; interleukin 7 hsa:3575 IL7R; interleukin 7 receptor hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:8651 SOCS1; suppressor of cytokine signaling 1 hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa04062 Chemokine signaling pathway - Homo sapiens (human) (27)

hsa05200 Pathways in cancer - Homo sapiens (human) (27)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:1630 DCC; deleted in colorectal carcinoma hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:2950 GSTP1; glutathione S-transferase pi 1 (EC:2.5.1.18) hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:4313 MMP2; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) hsa:4318 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:5468 PPARG; peroxisome proliferator-activated receptor gamma hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box) hsa:7040 TGFB1; transforming growth factor, beta 1

hsa05145 Toxoplasmosis - Homo sapiens (human) (26)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:1234 CCR5; chemokine (C-C motif) receptor 5 (gene/pseudogene) hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:4261 CIITA; class II, major histocompatibility complex, transactivator hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:8651 SOCS1; suppressor of cytokine signaling 1 hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa05142 Chagas disease (American trypanosomiasis) - Homo sapiens (human) (26)

hsa:1636 ACE; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:6348 CCL3; chemokine (C-C motif) ligand 3 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3558 IL2; interleukin 2 hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5054 SERPINE1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A

hsa04514 Cell adhesion molecules (CAMs) - Homo sapiens (human) (23)

hsa:10666 CD226; CD226 molecule hsa:940 CD28; CD28 molecule hsa:920 CD4; CD4 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:965 CD58; CD58 molecule hsa:923 CD6; CD6 molecule hsa:942 CD86; CD86 molecule hsa:26047 CNTNAP2; contactin associated protein-like 2 hsa:1493 CTLA4; cytotoxic T-lymphocyte-associated protein 4 hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:29851 ICOS; inducible T-cell co-stimulator hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:5133 PDCD1; programmed cell death 1 hsa:5788 PTPRC; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48) hsa:5817 PVR; poliovirus receptor hsa:6401 SELE; selectin E hsa:6404 SELPLG; selectin P ligand

hsa04620 Toll-like receptor signaling pathway - Homo sapiens (human) (23)

hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:6348 CCL3; chemokine (C-C motif) ligand 3 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:929 CD14; CD14 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:3627 CXCL10; chemokine (C-X-C motif) ligand 10 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3663 IRF5; interferon regulatory factor 5 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:6696 SPP1; secreted phosphoprotein 1 hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:7124 TNF; tumor necrosis factor

hsa05166 HTLV-I infection - Homo sapiens (human) (21)

hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3558 IL2; interleukin 2 hsa:3559 IL2RA; interleukin 2 receptor, alpha hsa:3560 IL2RB; interleukin 2 receptor, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:4049 LTA; lymphotoxin alpha (TNF superfamily, member 1) hsa:4602 MYB; v-myb myeloblastosis viral oncogene homolog (avian) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A

hsa05140 Leishmaniasis - Homo sapiens (human) (21) Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.

hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3565 IL4; interleukin 4 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa05169 Epstein-Barr virus infection - Homo sapiens (human) (21)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:965 CD58; CD58 molecule hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:5610 EIF2AK2; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2) hsa:7532 YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide

hsa04380 Osteoclast differentiation - Homo sapiens (human) (20)

hsa:54 ACP5; acid phosphatase 5, tartrate resistant (EC:3.1.3.2) hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3553 IL1B; interleukin 1, beta hsa:11026 LILRA3; leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:5468 PPARG; peroxisome proliferator-activated receptor gamma hsa:8651 SOCS1; suppressor of cytokine signaling 1 hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa05323 Rheumatoid arthritis - Homo sapiens (human) (20)

hsa:54 ACP5; acid phosphatase 5, tartrate resistant (EC:3.1.3.2) hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:6348 CCL3; chemokine (C-C motif) ligand 3 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:940 CD28; CD28 molecule hsa:942 CD86; CD86 molecule hsa:1493 CTLA4; cytotoxic T-lymphocyte-associated protein 4 hsa:6387 CXCL12; chemokine (C-X-C motif) ligand 12 hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3458 IFNG; interferon, gamma hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:4314 MMP3; matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa05332 Graft-versus-host disease - Homo sapiens (human) (20)

hsa:940 CD28; CD28 molecule hsa:942 CD86; CD86 molecule hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3458 IFNG; interferon, gamma hsa:3553 IL1B; interleukin 1, beta hsa:3558 IL2; interleukin 2 hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3802 KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 hsa:3803 KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 hsa:3804 KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 hsa:3811 KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 hsa:5551 PRF1; perforin 1 (pore forming protein) hsa:7124 TNF; tumor necrosis factor

hsa05330 Allograft rejection - Homo sapiens (human) (19)

hsa:940 CD28; CD28 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3558 IL2; interleukin 2 hsa:3565 IL4; interleukin 4 hsa:5551 PRF1; perforin 1 (pore forming protein) hsa:7124 TNF; tumor necrosis factor

hsa04660 T cell receptor signaling pathway - Homo sapiens (human) (19)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:940 CD28; CD28 molecule hsa:920 CD4; CD4 molecule hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:1493 CTLA4; cytotoxic T-lymphocyte-associated protein 4 hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:29851 ICOS; inducible T-cell co-stimulator hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:3558 IL2; interleukin 2 hsa:3565 IL4; interleukin 4 hsa:10892 MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:5133 PDCD1; programmed cell death 1 hsa:5788 PTPRC; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48) hsa:7124 TNF; tumor necrosis factor hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa05320 Autoimmune thyroid disease - Homo sapiens (human) (18)

hsa:940 CD28; CD28 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:1493 CTLA4; cytotoxic T-lymphocyte-associated protein 4 hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3586 IL10; interleukin 10 hsa:3558 IL2; interleukin 2 hsa:3565 IL4; interleukin 4 hsa:5551 PRF1; perforin 1 (pore forming protein)

hsa04612 Antigen processing and presentation - Homo sapiens (human) (18)

hsa:920 CD4; CD4 molecule hsa:4261 CIITA; class II, major histocompatibility complex, transactivator hsa:1520 CTSS; cathepsin S (EC:3.4.22.27) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:10437 IFI30; interferon, gamma-inducible protein 30 hsa:3458 IFNG; interferon, gamma hsa:3802 KIR2DL1; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 1 hsa:3803 KIR2DL2; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 2 hsa:3804 KIR2DL3; killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 hsa:3806 KIR2DS1; killer cell immunoglobulin-like receptor, two domains, short cytoplasmic tail, 1 hsa:3811 KIR3DL1; killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1 hsa:6891 TAP2; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP) hsa:7124 TNF; tumor necrosis factor

hsa04940 Type I diabetes mellitus - Homo sapiens (human) (18)

hsa:940 CD28; CD28 molecule hsa:942 CD86; CD86 molecule hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3458 IFNG; interferon, gamma hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3558 IL2; interleukin 2 hsa:4049 LTA; lymphotoxin alpha (TNF superfamily, member 1) hsa:5551 PRF1; perforin 1 (pore forming protein) hsa:7124 TNF; tumor necrosis factor

hsa05416 Viral myocarditis - Homo sapiens (human) (18)

hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:857 CAV1; caveolin 1, caveolae protein, 22kDa hsa:940 CD28; CD28 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:1756 DMD; dystrophin hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:4627 MYH9; myosin, heavy chain 9, non-muscle hsa:5551 PRF1; perforin 1 (pore forming protein) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6444 SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)

hsa05202 Transcriptional misregulation in cancer - Homo sapiens (human) (18)

hsa:929 CD14; CD14 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:2530 FUT8; fucosyltransferase 8 (alpha (1,6) fucosyltransferase) (EC:2.4.1.68) hsa:3087 HHEX; hematopoietically expressed homeobox hsa:3560 IL2RB; interleukin 2 receptor, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:4314 MMP3; matrix metallopeptidase 3 (stromelysin 1, progelatinase) (EC:3.4.24.17) hsa:4318 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) hsa:4353 MPO; myeloperoxidase (EC:1.11.2.2) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:9611 NCOR1; nuclear receptor corepressor 1 hsa:64332 NFKBIZ; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta hsa:5327 PLAT; plasminogen activator, tissue (EC:3.4.21.68) hsa:5468 PPARG; peroxisome proliferator-activated receptor gamma

hsa05160 Hepatitis C - Homo sapiens (human) (18)

hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:5610 EIF2AK2; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:3434 IFIT1; interferon-induced protein with tetratricopeptide repeats 1 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3454 IFNAR1; interferon (alpha, beta and omega) receptor 1 hsa:3455 IFNAR2; interferon (alpha, beta and omega) receptor 2 hsa:3576 IL8; interleukin 8 hsa:3659 IRF1; interferon regulatory factor 1 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4938 OAS1; 2'-5'-oligoadenylate synthetase 1, 40/46kDa (EC:2.7.7.-) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:7297 TYK2; tyrosine kinase 2 (EC:2.7.10.2)

hsa04640 Hematopoietic cell lineage - Homo sapiens (human) (17)

hsa:929 CD14; CD14 molecule hsa:909 CD1A; CD1a molecule hsa:913 CD1E; CD1e molecule hsa:100133941 CD24; CD24 molecule hsa:920 CD4; CD4 molecule hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3553 IL1B; interleukin 1, beta hsa:3559 IL2RA; interleukin 2 receptor, alpha hsa:3565 IL4; interleukin 4 hsa:3566 IL4R; interleukin 4 receptor hsa:3568 IL5RA; interleukin 5 receptor, alpha hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3574 IL7; interleukin 7 hsa:3575 IL7R; interleukin 7 receptor hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:7124 TNF; tumor necrosis factor

hsa05010 Alzheimer's disease - Homo sapiens (human) (16)

hsa:348 APOE; apolipoprotein E hsa:4508 ATP6; ATP synthase F0 subunit 6 hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:4519 CYTB; cytochrome b hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:3553 IL1B; interleukin 1, beta hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4725 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) hsa:374291 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:6263 RYR3; ryanodine receptor 3 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A

hsa05322 Systemic lupus erythematosus - Homo sapiens (human) (16)

hsa:87 ACTN1; actinin, alpha 1 hsa:720 C4A; complement component 4A (Rodgers blood group) hsa:727 C5; complement component 5 hsa:730 C7; complement component 7 hsa:940 CD28; CD28 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:7124 TNF; tumor necrosis factor

hsa05146 Amoebiasis - Homo sapiens (human) (16)

hsa:87 ACTN1; actinin, alpha 1 hsa:929 CD14; CD14 molecule hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa04672 Intestinal immune network for IgA production - Homo sapiens (human) (15)

hsa:940 CD28; CD28 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:942 CD86; CD86 molecule hsa:6387 CXCL12; chemokine (C-X-C motif) ligand 12 hsa:7852 CXCR4; chemokine (C-X-C motif) receptor 4 hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:29851 ICOS; inducible T-cell co-stimulator hsa:3586 IL10; interleukin 10 hsa:3558 IL2; interleukin 2 hsa:3565 IL4; interleukin 4 hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:7040 TGFB1; transforming growth factor, beta 1

hsa05133 Pertussis - Homo sapiens (human) (15)

hsa:720 C4A; complement component 4A (Rodgers blood group) hsa:727 C5; complement component 5 hsa:929 CD14; CD14 molecule hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3659 IRF1; interferon regulatory factor 1 hsa:3394 IRF8; interferon regulatory factor 8 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:7124 TNF; tumor necrosis factor

hsa05144 Malaria - Homo sapiens (human) (14)

hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3820 KLRB1; killer cell lectin-like receptor subfamily B, member 1 hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:6401 SELE; selectin E hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa04210 Apoptosis - Homo sapiens (human) (14)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3553 IL1B; interleukin 1, beta hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4803 NGF; nerve growth factor (beta polypeptide) hsa:7124 TNF; tumor necrosis factor hsa:8797 TNFRSF10A; tumor necrosis factor receptor superfamily, member 10a hsa:8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:8743 TNFSF10; tumor necrosis factor (ligand) superfamily, member 10

hsa04010 MAPK signaling pathway - Homo sapiens (human) (14)

hsa:627 BDNF; brain-derived neurotrophic factor hsa:929 CD14; CD14 molecule hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3553 IL1B; interleukin 1, beta hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:4803 NGF; nerve growth factor (beta polypeptide) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A

hsa05143 African trypanosomiasis - Homo sapiens (human) (14)

hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3458 IFNG; interferon, gamma hsa:3586 IL10; interleukin 10 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:6401 SELE; selectin E hsa:7124 TNF; tumor necrosis factor

hsa04144 Endocytosis - Homo sapiens (human) (14)

hsa:116986 AGAP2; ArfGAP with GTPase domain, ankyrin repeat and PH domain 2 hsa:50807 ASAP1; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 hsa:857 CAV1; caveolin 1, caveolae protein, 22kDa hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:1234 CCR5; chemokine (C-C motif) receptor 5 (gene/pseudogene) hsa:7852 CXCR4; chemokine (C-X-C motif) receptor 4 hsa:2065 ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3559 IL2RA; interleukin 2 receptor, alpha hsa:3560 IL2RB; interleukin 2 receptor, beta hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:6456 SH3GL2; SH3-domain GRB2-like 2 hsa:7040 TGFB1; transforming growth factor, beta 1

hsa04145 Phagosome - Homo sapiens (human) (13)

hsa:929 CD14; CD14 molecule hsa:1520 CTSS; cathepsin S (EC:3.4.22.27) hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3105 HLA-A; major histocompatibility complex, class I, A hsa:3106 HLA-B; major histocompatibility complex, class I, B hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:4353 MPO; myeloperoxidase (EC:1.11.2.2) hsa:6891 TAP2; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)

hsa05150 Staphylococcus aureus infection - Homo sapiens (human) (13)

hsa:720 C4A; complement component 4A (Rodgers blood group) hsa:727 C5; complement component 5 hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:2215 FCGR3B; Fc fragment of IgG, low affinity IIIb, receptor (CD16b) hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3586 IL10; interleukin 10 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:5724 PTAFR; platelet-activating factor receptor hsa:6404 SELPLG; selectin P ligand

hsa04621 NOD-like receptor signaling pathway - Homo sapiens (human) (12)

hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:6347 CCL2; chemokine (C-C motif) ligand 2 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4210 MEFV; Mediterranean fever hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:64127 NOD2; nucleotide-binding oligomerization domain containing 2 hsa:7124 TNF; tumor necrosis factor

hsa04510 Focal adhesion - Homo sapiens (human) (12)

hsa:87 ACTN1; actinin, alpha 1 hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:857 CAV1; caveolin 1, caveolae protein, 22kDa hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:5649 RELN; reelin hsa:6696 SPP1; secreted phosphoprotein 1 hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa04080 Neuroactive ligand-receptor interaction - Homo sapiens (human) (11)

hsa:1131 CHRM3; cholinergic receptor, muscarinic 3 hsa:1268 CNR1; cannabinoid receptor 1 (brain) hsa:1394 CRHR1; corticotropin releasing hormone receptor 1 hsa:2556 GABRA3; gamma-aminobutyric acid (GABA) A receptor, alpha 3 hsa:2693 GHSR; growth hormone secretagogue receptor hsa:2696 GIPR; gastric inhibitory polypeptide receptor hsa:4157 MC1R; melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) hsa:2908 NR3C1; nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor) hsa:5027 P2RX7; purinergic receptor P2X, ligand-gated ion channel, 7 hsa:5724 PTAFR; platelet-activating factor receptor hsa:5734 PTGER4; prostaglandin E receptor 4 (subtype EP4)

hsa05132 Salmonella infection - Homo sapiens (human) (11)

hsa:6348 CCL3; chemokine (C-C motif) ligand 3 hsa:929 CD14; CD14 molecule hsa:3458 IFNG; interferon, gamma hsa:3460 IFNGR2; interferon gamma receptor 2 (interferon gamma transducer 1) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3831 KLC1; kinesin light chain 1 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4627 MYH9; myosin, heavy chain 9, non-muscle hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39)

hsa04666 Fc gamma R-mediated phagocytosis - Homo sapiens (human) (11)

hsa:50807 ASAP1; ArfGAP with SH3 domain, ankyrin repeat and PH domain 1 hsa:2212 FCGR2A; Fc fragment of IgG, low affinity IIa, receptor (CD32) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5788 PTPRC; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) hsa:85477 SCIN; scinderin hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa04670 Leukocyte transendothelial migration - Homo sapiens (human) (11)

hsa:87 ACTN1; actinin, alpha 1 hsa:6387 CXCL12; chemokine (C-X-C motif) ligand 12 hsa:7852 CXCR4; chemokine (C-X-C motif) receptor 4 hsa:3383 ICAM1; intercellular adhesion molecule 1 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:4313 MMP2; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) hsa:4318 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa05134 Legionellosis - Homo sapiens (human) (11)

hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:929 CD14; CD14 molecule hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:3576 IL8; interleukin 8 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:7124 TNF; tumor necrosis factor

hsa04622 RIG-I-like receptor signaling pathway - Homo sapiens (human) (11)

hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:3627 CXCL10; chemokine (C-X-C motif) ligand 10 hsa:64135 IFIH1; interferon induced with helicase C domain 1 (EC:3.6.4.13) hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3592 IL12A; interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) hsa:3593 IL12B; interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) hsa:3576 IL8; interleukin 8 hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:7124 TNF; tumor necrosis factor

hsa04810 Regulation of actin cytoskeleton - Homo sapiens (human) (10)

hsa:87 ACTN1; actinin, alpha 1 hsa:929 CD14; CD14 molecule hsa:1131 CHRM3; cholinergic receptor, muscarinic 3 hsa:3684 ITGAM; integrin, alpha M (complement component 3 receptor 3 subunit) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4627 MYH9; myosin, heavy chain 9, non-muscle hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:85477 SCIN; scinderin hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa05012 Parkinson's disease - Homo sapiens (human) (10)

hsa:4508 ATP6; ATP synthase F0 subunit 6 hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:4519 CYTB; cytochrome b hsa:4535 ND1; NADH dehydrogenase, subunit 1 (complex I) hsa:4536 ND2; MTND2 hsa:4537 ND3; NADH dehydrogenase, subunit 3 (complex I) hsa:4538 ND4; NADH dehydrogenase, subunit 4 (complex I) hsa:4540 ND5; NADH dehydrogenase, subunit 5 (complex I) hsa:4725 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) hsa:374291 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)

hsa05016 Huntington's disease - Homo sapiens (human) (10)

hsa:4508 ATP6; ATP synthase F0 subunit 6 hsa:627 BDNF; brain-derived neurotrophic factor hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:4519 CYTB; cytochrome b hsa:4725 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) hsa:374291 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5468 PPARG; peroxisome proliferator-activated receptor gamma

hsa05210 Colorectal cancer - Homo sapiens (human) (9)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:1630 DCC; deleted in colorectal carcinoma hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box) hsa:7040 TGFB1; transforming growth factor, beta 1

hsa04662 B cell receptor signaling pathway - Homo sapiens (human) (9)

hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:10892 MALT1; mucosa associated lymphoid tissue lymphoma translocation gene 1 (EC:3.4.22.-) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa05310 Asthma - Homo sapiens (human) (9)

hsa:6356 CCL11; chemokine (C-C motif) ligand 11 hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:3117 HLA-DQA1; major histocompatibility complex, class II, DQ alpha 1 hsa:3119 HLA-DQB1; major histocompatibility complex, class II, DQ beta 1 hsa:3122 HLA-DRA; major histocompatibility complex, class II, DR alpha hsa:3123 HLA-DRB1; major histocompatibility complex, class II, DR beta 1 hsa:3586 IL10; interleukin 10 hsa:3565 IL4; interleukin 4 hsa:7124 TNF; tumor necrosis factor

hsa00190 Oxidative phosphorylation - Homo sapiens (human) (9)

hsa:4508 ATP6; ATP synthase F0 subunit 6 hsa:4519 CYTB; cytochrome b hsa:4535 ND1; NADH dehydrogenase, subunit 1 (complex I) hsa:4536 ND2; MTND2 hsa:4537 ND3; NADH dehydrogenase, subunit 3 (complex I) hsa:4538 ND4; NADH dehydrogenase, subunit 4 (complex I) hsa:4540 ND5; NADH dehydrogenase, subunit 5 (complex I) hsa:4725 NDUFS5; NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase) hsa:374291 NDUFS7; NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) (EC:1.6.5.3 1.6.99.3)

hsa04020 Calcium signaling pathway - Homo sapiens (human) (9)

hsa:1131 CHRM3; cholinergic receptor, muscarinic 3 hsa:2065 ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1) hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:5027 P2RX7; purinergic receptor P2X, ligand-gated ion channel, 7 hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5724 PTAFR; platelet-activating factor receptor hsa:6263 RYR3; ryanodine receptor 3

hsa04722 Neurotrophin signaling pathway - Homo sapiens (human) (9)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:627 BDNF; brain-derived neurotrophic factor hsa:356 FASLG; Fas ligand (TNF superfamily, member 6) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4803 NGF; nerve growth factor (beta polypeptide) hsa:10019 SH2B3; SH2B adaptor protein 3 hsa:7532 YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide

hsa04664 Fc epsilon RI signaling pathway - Homo sapiens (human) (8)

hsa:3565 IL4; interleukin 4 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6850 SYK; spleen tyrosine kinase (EC:2.7.10.2) hsa:7124 TNF; tumor necrosis factor hsa:7409 VAV1; vav 1 guanine nucleotide exchange factor hsa:7410 VAV2; vav 2 guanine nucleotide exchange factor

hsa04310 Wnt signaling pathway - Homo sapiens (human) (8)

hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:4041 LRP5; low density lipoprotein receptor-related protein 5 hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa04623 Cytosolic DNA-sensing pathway - Homo sapiens (human) (8)

hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:3627 CXCL10; chemokine (C-X-C motif) ligand 10 hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha

hsa05215 Prostate cancer - Homo sapiens (human) (8)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:2950 GSTP1; glutathione S-transferase pi 1 (EC:2.5.1.18) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa04012 ErbB signaling pathway - Homo sapiens (human) (7)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:2065 ERBB3; v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) (EC:2.7.10.1) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1)

hsa04723 Retrograde endocannabinoid signaling - Homo sapiens (human) (7)

hsa:1268 CNR1; cannabinoid receptor 1 (brain) hsa:2556 GABRA3; gamma-aminobutyric acid (GABA) A receptor, alpha 3 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)

hsa04360 Axon guidance - Homo sapiens (human) (7)

hsa:6387 CXCL12; chemokine (C-X-C motif) ligand 12 hsa:7852 CXCR4; chemokine (C-X-C motif) receptor 4 hsa:1630 DCC; deleted in colorectal carcinoma hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)

hsa05340 Primary immunodeficiency - Homo sapiens (human) (7)

hsa:920 CD4; CD4 molecule hsa:958 CD40; CD40 molecule, TNF receptor superfamily member 5 hsa:4261 CIITA; class II, major histocompatibility complex, transactivator hsa:29851 ICOS; inducible T-cell co-stimulator hsa:3575 IL7R; interleukin 7 receptor hsa:5788 PTPRC; protein tyrosine phosphatase, receptor type, C (EC:3.1.3.48) hsa:6891 TAP2; transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)

hsa05222 Small cell lung cancer - Homo sapiens (human) (7)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:4843 NOS2; nitric oxide synthase 2, inducible (EC:1.14.13.39) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)

hsa05212 Pancreatic cancer - Homo sapiens (human) (7)

hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6772 STAT1; signal transducer and activator of transcription 1, 91kDa hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:7040 TGFB1; transforming growth factor, beta 1

hsa04916 Melanogenesis - Homo sapiens (human) (7)

hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4157 MC1R; melanocortin 1 receptor (alpha melanocyte stimulating hormone receptor) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa05221 Acute myeloid leukemia - Homo sapiens (human) (6)

hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa04610 Complement and coagulation cascades - Homo sapiens (human) (6)

hsa:720 C4A; complement component 4A (Rodgers blood group) hsa:727 C5; complement component 5 hsa:730 C7; complement component 7 hsa:4179 CD46; CD46 molecule, complement regulatory protein hsa:5327 PLAT; plasminogen activator, tissue (EC:3.4.21.68) hsa:5054 SERPINE1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1

hsa04350 TGF-beta signaling pathway - Homo sapiens (human) (6)

hsa:3458 IFNG; interferon, gamma hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa04142 Lysosome - Homo sapiens (human) (6)

hsa:54 ACP5; acid phosphatase 5, tartrate resistant (EC:3.1.3.2) hsa:410 ARSA; arylsulfatase A (EC:3.1.6.8) hsa:1520 CTSS; cathepsin S (EC:3.4.22.27) hsa:4126 MANBA; mannosidase, beta A, lysosomal (EC:3.2.1.25) hsa:6556 SLC11A1; solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 hsa:285362 SUMF1; sulfatase modifying factor 1 (EC:1.13.-.-)

hsa04725 Cholinergic synapse - Homo sapiens (human) (6)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:1131 CHRM3; cholinergic receptor, muscarinic 3 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04970 Salivary secretion - Homo sapiens (human) (6)

hsa:1131 CHRM3; cholinergic receptor, muscarinic 3 hsa:486 FXYD2; FXYD domain containing ion transport regulator 2 hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:6263 RYR3; ryanodine receptor 3

hsa05410 Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human) (6)

hsa:1636 ACE; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) hsa:1756 DMD; dystrophin hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:6444 SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa05020 Prion diseases - Homo sapiens (human) (6)

hsa:727 C5; complement component 5 hsa:730 C7; complement component 7 hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:3553 IL1B; interleukin 1, beta hsa:3569 IL6; interleukin 6 (interferon, beta 2) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24)

hsa05220 Chronic myeloid leukemia - Homo sapiens (human) (6)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:7040 TGFB1; transforming growth factor, beta 1

hsa04961 Endocrine and other factor-regulated calcium reabsorption - Homo sapiens (human) (6)

hsa:2099 ESR1; estrogen receptor 1 hsa:486 FXYD2; FXYD domain containing ion transport regulator 2 hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:7421 VDR; vitamin D (1,25- dihydroxyvitamin D3) receptor

hsa04912 GnRH signaling pathway - Homo sapiens (human) (5)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4313 MMP2; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04370 VEGF signaling pathway - Homo sapiens (human) (5)

hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)

hsa05120 Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human) (5)

hsa:6352 CCL5; chemokine (C-C motif) ligand 5 hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:3576 IL8; interleukin 8 hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha

hsa05014 Amyotrophic lateral sclerosis (ALS) - Homo sapiens (human) (5)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A hsa:10452 TOMM40; translocase of outer mitochondrial membrane 40 homolog (yeast)

hsa05131 Shigellosis - Homo sapiens (human) (5)

hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:3576 IL8; interleukin 8 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:64127 NOD2; nucleotide-binding oligomerization domain containing 2

hsa04520 Adherens junction - Homo sapiens (human) (5)

hsa:87 ACTN1; actinin, alpha 1 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:5880 RAC2; ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa05213 Endometrial cancer - Homo sapiens (human) (5)

hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa05219 Bladder cancer - Homo sapiens (human) (5)

hsa:3576 IL8; interleukin 8 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4313 MMP2; matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) (EC:3.4.24.24) hsa:4318 MMP9; matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase) (EC:3.4.24.35) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian)

hsa04726 Serotonergic synapse - Homo sapiens (human) (5)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13) hsa:5743 PTGS2; prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1)

hsa04910 Insulin signaling pathway - Homo sapiens (human) (5)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1) hsa:8651 SOCS1; suppressor of cytokine signaling 1

hsa04972 Pancreatic secretion - Homo sapiens (human) (5)

hsa04730 Long-term depression - Homo sapiens (human) (5)

hsa:1394 CRHR1; corticotropin releasing hormone receptor 1 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04728 Dopaminergic synapse - Homo sapiens (human) (5)

hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:3798 KIF5A; kinesin family member 5A hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04920 Adipocytokine signaling pathway - Homo sapiens (human) (5)

hsa:1147 CHUK; conserved helix-loop-helix ubiquitous kinase (EC:2.7.11.10) hsa:4792 NFKBIA; nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha hsa:6774 STAT3; signal transducer and activator of transcription 3 (acute-phase response factor) hsa:7124 TNF; tumor necrosis factor hsa:7132 TNFRSF1A; tumor necrosis factor receptor superfamily, member 1A

hsa04115 p53 signaling pathway - Homo sapiens (human) (5)

hsa:841 CASP8; caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:355 FAS; Fas (TNF receptor superfamily, member 6) hsa:5054 SERPINE1; serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 hsa:8795 TNFRSF10B; tumor necrosis factor receptor superfamily, member 10b

hsa04540 Gap junction - Homo sapiens (human) (4)

hsa05412 Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human) (4)

hsa:87 ACTN1; actinin, alpha 1 hsa:1756 DMD; dystrophin hsa:6444 SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa04110 Cell cycle - Homo sapiens (human) (4)

hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7532 YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide

hsa05216 Thyroid cancer - Homo sapiens (human) (4)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4609 MYC; v-myc myelocytomatosis viral oncogene homolog (avian) hsa:5468 PPARG; peroxisome proliferator-activated receptor gamma hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa04720 Long-term potentiation - Homo sapiens (human) (4)

hsa04070 Phosphatidylinositol signaling system - Homo sapiens (human) (4)

hsa:3632 INPP5A; inositol polyphosphate-5-phosphatase, 40kDa (EC:3.1.3.56) hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04141 Protein processing in endoplasmic reticulum - Homo sapiens (human) (4)

hsa:596 BCL2; B-cell CLL/lymphoma 2 hsa:1410 CRYAB; crystallin, alpha B hsa:5610 EIF2AK2; eukaryotic translation initiation factor 2-alpha kinase 2 (EC:2.7.11.1 2.7.10.2) hsa:10956 OS9; osteosarcoma amplified 9, endoplasmic reticulum lectin

hsa05414 Dilated cardiomyopathy - Homo sapiens (human) (4)

hsa:1756 DMD; dystrophin hsa:6444 SGCD; sarcoglycan, delta (35kDa dystrophin-associated glycoprotein) hsa:7040 TGFB1; transforming growth factor, beta 1 hsa:7124 TNF; tumor necrosis factor

hsa04971 Gastric acid secretion - Homo sapiens (human) (4)

hsa:1131 CHRM3; cholinergic receptor, muscarinic 3 hsa:23236 PLCB1; phospholipase C, beta 1 (phosphoinositide-specific) (EC:3.1.4.11) hsa:5332 PLCB4; phospholipase C, beta 4 (EC:3.1.4.11) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04270 Vascular smooth muscle contraction - Homo sapiens (human) (4)

hsa04724 Glutamatergic synapse - Homo sapiens (human) (4)

hsa04140 Regulation of autophagy - Homo sapiens (human) (3)

hsa:3451 IFNA17; interferon, alpha 17 hsa:3440 IFNA2; interferon, alpha 2 hsa:3458 IFNG; interferon, gamma

hsa05223 Non-small cell lung cancer - Homo sapiens (human) (3)

hsa:842 CASP9; caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa00562 Inositol phosphate metabolism - Homo sapiens (human) (3)

hsa04978 Mineral absorption - Homo sapiens (human) (3)

hsa:486 FXYD2; FXYD domain containing ion transport regulator 2 hsa:6556 SLC11A1; solute carrier family 11 (proton-coupled divalent metal ion transporters), member 1 hsa:7421 VDR; vitamin D (1,25- dihydroxyvitamin D3) receptor

hsa05211 Renal cell carcinoma - Homo sapiens (human) (3)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1) hsa:7040 TGFB1; transforming growth factor, beta 1

hsa04960 Aldosterone-regulated sodium reabsorption - Homo sapiens (human) (3)

hsa:486 FXYD2; FXYD domain containing ion transport regulator 2 hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04727 GABAergic synapse - Homo sapiens (human) (3)

hsa:2556 GABRA3; gamma-aminobutyric acid (GABA) A receptor, alpha 3 hsa:5334 PLCL1; phospholipase C-like 1 hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04120 Ubiquitin mediated proteolysis - Homo sapiens (human) (3)

hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:10055 SAE1; SUMO1 activating enzyme subunit 1 hsa:8651 SOCS1; suppressor of cytokine signaling 1

hsa04530 Tight junction - Homo sapiens (human) (3)

hsa:87 ACTN1; actinin, alpha 1 hsa:4627 MYH9; myosin, heavy chain 9, non-muscle hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa05032 Morphine addiction - Homo sapiens (human) (3)

hsa:2556 GABRA3; gamma-aminobutyric acid (GABA) A receptor, alpha 3 hsa:5142 PDE4B; phosphodiesterase 4B, cAMP-specific (EC:3.1.4.17) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa00480 Glutathione metabolism - Homo sapiens (human) (3)

hsa:2944 GSTM1; glutathione S-transferase mu 1 (EC:2.5.1.18) hsa:2947 GSTM3; glutathione S-transferase mu 3 (brain) (EC:2.5.1.18) hsa:2950 GSTP1; glutathione S-transferase pi 1 (EC:2.5.1.18)

hsa05100 Bacterial invasion of epithelial cells - Homo sapiens (human) (3)

hsa:857 CAV1; caveolin 1, caveolae protein, 22kDa hsa:868 CBLB; Cbl proto-oncogene, E3 ubiquitin protein ligase B hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1)

hsa00982 Drug metabolism - cytochrome P450 - Homo sapiens (human) (3)

hsa:2944 GSTM1; glutathione S-transferase mu 1 (EC:2.5.1.18) hsa:2947 GSTM3; glutathione S-transferase mu 3 (brain) (EC:2.5.1.18) hsa:2950 GSTP1; glutathione S-transferase pi 1 (EC:2.5.1.18)

hsa03050 Proteasome - Homo sapiens (human) (3)

hsa:3458 IFNG; interferon, gamma hsa:5696 PSMB8; proteasome (prosome, macropain) subunit, beta type, 8 (large multifunctional peptidase 7) (EC:3.4.25.1) hsa:5698 PSMB9; proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) (EC:3.4.25.1)

hsa04930 Type II diabetes mellitus - Homo sapiens (human) (3)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:8651 SOCS1; suppressor of cytokine signaling 1 hsa:7124 TNF; tumor necrosis factor

hsa00100 Steroid biosynthesis - Homo sapiens (human) (3)

hsa:1591 CYP24A1; cytochrome P450, family 24, subfamily A, polypeptide 1 (EC:1.14.13.126) hsa:1594 CYP27B1; cytochrome P450, family 27, subfamily B, polypeptide 1 (EC:1.14.13.13) hsa:1717 DHCR7; 7-dehydrocholesterol reductase (EC:1.3.1.21)

hsa00980 Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human) (3)

hsa:2944 GSTM1; glutathione S-transferase mu 1 (EC:2.5.1.18) hsa:2947 GSTM3; glutathione S-transferase mu 3 (brain) (EC:2.5.1.18) hsa:2950 GSTP1; glutathione S-transferase pi 1 (EC:2.5.1.18)

hsa04614 Renin-angiotensin system - Homo sapiens (human) (2)

hsa:1636 ACE; angiotensin I converting enzyme (peptidyl-dipeptidase A) 1 (EC:3.4.15.1) hsa:183 AGT; angiotensinogen (serpin peptidase inhibitor, clade A, member 8)

hsa04150 mTOR signaling pathway - Homo sapiens (human) (2)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:6198 RPS6KB1; ribosomal protein S6 kinase, 70kDa, polypeptide 1 (EC:2.7.11.1)

hsa04976 Bile secretion - Homo sapiens (human) (2)

hsa:486 FXYD2; FXYD domain containing ion transport regulator 2 hsa:57835 SLC4A5; solute carrier family 4, sodium bicarbonate cotransporter, member 5

hsa00740 Riboflavin metabolism - Homo sapiens (human) (2)

hsa:54 ACP5; acid phosphatase 5, tartrate resistant (EC:3.1.3.2) hsa:55312 RFK; riboflavin kinase (EC:2.7.1.26)

hsa05130 Pathogenic Escherichia coli infection - Homo sapiens (human) (2)

hsa:929 CD14; CD14 molecule hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04740 Olfactory transduction - Homo sapiens (human) (2)

hsa:401992 OR2T2; olfactory receptor, family 2, subfamily T, member 2 hsa:403253 OR4A47; olfactory receptor, family 4, subfamily A, member 47

hsa00534 Glycosaminoglycan biosynthesis - heparan sulfate - Homo sapiens (human) (2)

hsa:2135 EXTL2; exostoses (multiple)-like 2 (EC:2.4.1.223) hsa:9953 HS3ST3B1; heparan sulfate (glucosamine) 3-O-sulfotransferase 3B1 (EC:2.8.2.30)

hsa04512 ECM-receptor interaction - Homo sapiens (human) (2)

hsa:5649 RELN; reelin hsa:6696 SPP1; secreted phosphoprotein 1

hsa00564 Glycerophospholipid metabolism - Homo sapiens (human) (2)

hsa:23171 GPD1L; glycerol-3-phosphate dehydrogenase 1-like (EC:1.1.1.8) hsa:10162 LPCAT3; lysophosphatidylcholine acyltransferase 3 (EC:2.3.1.23)

hsa05218 Melanoma - Homo sapiens (human) (2)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:4233 MET; met proto-oncogene (hepatocyte growth factor receptor) (EC:2.7.10.1)

hsa04330 Notch signaling pathway - Homo sapiens (human) (2)

hsa:182 JAG1; jagged 1 hsa:4855 NOTCH4; notch 4

hsa05034 Alcoholism - Homo sapiens (human) (2)

hsa:627 BDNF; brain-derived neurotrophic factor hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24)

hsa05214 Glioma - Homo sapiens (human) (2)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:5578 PRKCA; protein kinase C, alpha (EC:2.7.11.13)

hsa04114 Oocyte meiosis - Homo sapiens (human) (2)

hsa:5594 MAPK1; mitogen-activated protein kinase 1 (EC:2.7.11.24) hsa:7532 YWHAG; tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide

hsa00601 Glycosphingolipid biosynthesis - lacto and neolacto series - Homo sapiens (human) (2)

hsa:10317 B3GALT5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 hsa:6489 ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (EC:2.4.99.8)

hsa00603 Glycosphingolipid biosynthesis - globo series - Homo sapiens (human) (2)

hsa:10317 B3GALT5; UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 hsa:6489 ST8SIA1; ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (EC:2.4.99.8)

hsa05217 Basal cell carcinoma - Homo sapiens (human) (2)

hsa:2932 GSK3B; glycogen synthase kinase 3 beta (EC:2.7.11.1 2.7.11.26) hsa:6932 TCF7; transcription factor 7 (T-cell specific, HMG-box)

hsa00350 Tyrosine metabolism - Homo sapiens (human) (2)

hsa:4282 MIF; macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) hsa:5409 PNMT; phenylethanolamine N-methyltransferase (EC:2.1.1.28)

hsa04260 Cardiac muscle contraction - Homo sapiens (human) (2)